Journal article
Rationale for high-dose isoniazid in the treatment of multidrug-resistant tuberculosis.
- Rieder HL Epidemiology, Biostatistics and Prevention Institute, University of Zürich, Zürich, Switzerland. TBRieder@tbrieder.org.
- Van Deun A Mycobacteriology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
- 2017-02-04
Published in:
- The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. - 2017
Antitubercular Agents
Humans
Isoniazid
Mycobacterium tuberculosis
Rifampin
Tuberculosis, Multidrug-Resistant
- Language
-
- English
- Open access status
- closed
- Identifiers
-
- DOI 10.5588/ijtld.16.0619
- PMID 28157478
- Persistent URL
- https://sonar.ch/global/documents/298439
Statistics
Document views: 27
File downloads: